Keyphrases
Cost-effectiveness
100%
Acid Activation
100%
Induced Fluorescence
100%
Glioma Surgery
100%
5-Aminolevulinic Acid (5-ALA)
100%
Malignant Glioma
100%
Incremental Cost
75%
Quality-adjusted Life Years
50%
Gross Total Resection
50%
Spain
25%
Sociedad
25%
Clinical Practice
25%
Sensitivity Analysis
25%
White Light
25%
Practice Conditions
25%
Surgical Practice
25%
Hospital Costs
25%
Life-years Gained
25%
Conventional Surgery
25%
Gliolan
25%
Cost-effectiveness Ratio
25%
Medicine and Dentistry
Glioblastoma
100%
Cost-Effectiveness Analysis
100%
Aminolevulinic Acid
100%
Health Care Cost
80%
Surgery
60%
Quality Adjusted Life Year
40%
Observational Study
20%
Hospital Cost
20%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Aminolevulinic Acid
100%
Observational Study
20%